Annexon, Inc. - common stock (ANNX)
1.7050
-0.1250 (-6.83%)
NASDAQ · Last Trade: Apr 5th, 12:54 PM EDT
Via Benzinga · March 17, 2025

ANNX stock results show that Annexon met analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 12, 2024

Via Benzinga · July 12, 2024

ANNX stock results show that Annexon beat analyst estimates for earnings per share the first quarter of 2024.
Via InvestorPlace · May 13, 2024

ANNX stock results show that Annexon beat analyst estimates for earnings per share the fourth quarter of 2023.
Via InvestorPlace · March 26, 2024

While blue-chip stocks are great, it's also a good idea to invest in top stocks under $10 to help improve your portfolio's diversification.
Via InvestorPlace · June 24, 2024

Via Benzinga · June 5, 2024

Via Benzinga · June 5, 2024

Via Benzinga · June 4, 2024

Via Benzinga · June 4, 2024

Annexon reports positive Phase 3 trial results for ANX005 in Guillain-Barré syndrome, showing significant improvements in disability, muscle strength, and ventilation duration.
Via Benzinga · June 4, 2024

Via Benzinga · June 4, 2024

Via Benzinga · June 4, 2024

Via Benzinga · June 4, 2024

It's time to start Tuesday with a breakdown of the biggest pre-market stock movers traders will want to know about this morning!
Via InvestorPlace · June 4, 2024

Via Benzinga · June 4, 2024

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.
Via Benzinga · March 27, 2024

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.
Via Benzinga · March 22, 2024

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.
Via Benzinga · March 22, 2024

Via Benzinga · March 14, 2024

Via Benzinga · March 13, 2024

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.
Via Benzinga · March 13, 2024